PHAS
Northern Trust’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-58,119
| Closed | -$10K | – | 4764 |
|
|
2022
Q3 | $10K | Hold |
58,119
| – | – | ﹤0.01% | 4646 |
|
|
2022
Q2 | $35K | Hold |
58,119
| – | – | ﹤0.01% | 4518 |
|
|
2022
Q1 | $77K | Sell |
58,119
-4,587
| -7% | -$6.08K | ﹤0.01% | 4429 |
|
|
2021
Q4 | $164K | Hold |
62,706
| – | – | ﹤0.01% | 4265 |
|
|
2021
Q3 | $195K | Sell |
62,706
-1,775
| -3% | -$5.52K | ﹤0.01% | 4196 |
|
|
2021
Q2 | $240K | Sell |
64,481
-102,783
| -61% | -$383K | ﹤0.01% | 4076 |
|
|
2021
Q1 | $579K | Buy |
167,264
+1,924
| +1% | +$6.66K | ﹤0.01% | 3768 |
|
|
2020
Q4 | $556K | Sell |
165,340
-1,599
| -1% | -$5.38K | ﹤0.01% | 3699 |
|
|
2020
Q3 | $586K | Buy |
166,939
+316
| +0.2% | +$1.11K | ﹤0.01% | 3569 |
|
|
2020
Q2 | $766K | Sell |
166,623
-4,458
| -3% | -$20.5K | ﹤0.01% | 3440 |
|
|
2020
Q1 | $566K | Buy |
171,081
+28,688
| +20% | +$94.9K | ﹤0.01% | 3417 |
|
|
2019
Q4 | $870K | Sell |
142,393
-13,027
| -8% | -$79.6K | ﹤0.01% | 3437 |
|
|
2019
Q3 | $648K | Buy |
155,420
+118,393
| +320% | +$494K | ﹤0.01% | 3494 |
|
|
2019
Q2 | $486K | Buy |
+37,027
| New | +$486K | ﹤0.01% | 3557 |
|